Podcasts about Daichi

Daichi 04.28.25 | VISLA FM by VISLA

the incredible journey of Daichi Kamada, Japan's versatile midfield maestro who has taken European football by storm. Daichi Kamada is a Japanese professional footballer who plays as an attacking midfielder or forward for Premier League club Crystal Palace and the Japan national team. Daichi Kamada, Eintracht Frankfurt, Crystal Palace, Japan national team, UEFA Europa League, Bundesliga, Premier League, midfield maestro, football podcast, rising football stars, versatile midfielder, World Cup, Oliver Glasner.

Episode #352 of BGMania: A Video Game Music Podcast. This week on the show, Bryan and Bedroth from RPGera kick off 2025 and the new year by focusing on a console that never really took off in the mid-90s, the 3DO! Email the show at bgmaniapodcast@gmail.com with requests for upcoming episodes, questions, feedback, comments, concerns, or whatever you want! Special thanks to our Executive Producers: Jexak, Xancu, & Jeff. EPISODE PLAYLIST AND CREDITS Uranus' Theme from Pretty Soldier: Sailor Moon S [Shinji Amagishi, Akihito Suita, Chatru & Bishōjo Club, 1995] BGM 2 from Armageddon [Unknown, 1996] Daichi from Guardian War [Yasufumi Fukuda & Yukiharu Urita, 1994] Opera 4 from The Lost Files of Sherlock Holmes [Rob Hubbard, 1994] Hyperspace from Star Control 2 [Burke Trieschmann, Dan Nicholson, Riku Nuottajärvi, Eric Berge, Erol Otus, Marc Brown, Aaron J. Grier, Kevin Palivec & Tommy V. Dunbar, 1994] Reverend Bea Atch -Mission 6- from Blade Force [Nick Lockwood, 1995] Heavy Metal from The Even More Incredible Machine [Christopher Stevens, 1994] Earth from Trip'd [Unknown, 1994] Frozen Castle & Pit -Stage 1 & 8, otherwise known as Thunder Kiss '65- from Way of the Warrior [White Zombie, 1994] Track 3 from Yuu Yuu Hakusho [Kuomintang 3, STUDIO M2, Sound Factory Hibiki & Akihito Suita, 1994] Secret Level from Total Eclipse [Burke Trieschmann, 1994] Wastelands from Demolition Man [Keith Arem, Tommy Tallarico & Charlie Malone, 1994] Credits -Resurrection- from Rise of the Robots [Brian May, 1995] Intro & Rap from Captain Quazar [Burke Trieschmann, 1996] SUPPORT US Patreon: https://patreon.com/rpgera CONTACT US Website: https://rpgera.com Discord: https://discord.gg/cC73Heu Twitch: https://twitch.tv/therpgera Twitter: https://twitter.com/OriginalLDG Instagram: https://instagram.com/bryan.ldg/ Facebook: https://facebook.com/leveldowngaming RPGERA PODCAST NETWORK Very Good Music: A VGM Podcast The Movie Bar

Fluent Fiction - Japanese: Embracing Light: A Journey Through Healing and Friendship Find the full episode transcript, vocabulary words, and more:fluentfiction.org/embracing-light-a-journey-through-healing-and-friendship Story Transcript:Ja: 秋の風が優しく吹く嵐山竹林の中で、サクラは静かに立っていました。En: In the gently blowing autumn breeze within the bamboo grove of Arashiyama, Sakura stood quietly.Ja: 周りの背の高い竹が日光を和らげ、揺れる葉が優雅に空を飾っています。En: The tall bamboos around her softened the sunlight, while the swaying leaves elegantly adorned the sky.Ja: 彼女の心はしんどい頭痛の影、そして彼女が抱える秘密でいっぱいでした。En: Her heart was filled with the shadow of a persistent headache and the secret she carried.Ja: サクラは美術の学生で、学校の成績は素晴らしいものでした。しかし、最近、彼女の頭痛は悪化し、キャンバスに向かうことさえ難しくなっています。En: Sakura was an art student with outstanding grades, but recently, her headaches had worsened, making it difficult even to face her canvas.Ja: 奨学金を失うことを恐れて、彼女は誰にもそのことを話しませんでした。En: Fearing the loss of her scholarship, she hadn't told anyone about her struggles.Ja: サクラの親友であるダイチは、サクラの様子がおかしいことに気づいていました。En: Sakura's best friend, Daichi, had noticed something was off about her.Ja: 「最近の君はどこかおかしい」と彼は何度も彼女に言います。En: "You've been acting strange lately," he repeatedly told her.Ja: しかし、サクラは微笑むだけで、自分の問題を隠し続けました。En: However, Sakura only smiled, continuing to hide her problems.Ja: 秋分の日、竹林でダイチと一緒にいると、サクラの頭痛は今までで最もひどくなりました。En: On the autumn equinox, while in the bamboo grove with Daichi, Sakura's headache became more severe than ever before.Ja: 彼女はその場に座り込み、頬に涙が流れます。En: She sat down, tears streaming down her cheeks.Ja: その時、ハルトという名の年老いた薬草師が近づいてきました。En: At that moment, an elderly herbalist named Haruto approached.Ja: 「頭が痛いのかい？」と彼は優しく尋ねます。En: "Do you have a headache?" he gently asked.Ja: サクラはうなずき、初めて自分の苦しみを他人に打ち明けました。En: Sakura nodded, for the first time confiding her suffering in another person.Ja: ハルトは竹林の中で採れる草を使った薬を彼女に提案しました。En: Haruto suggested a remedy made from herbs found within the bamboo grove.Ja: 「これを試してみなさい。きっと助けになる」と彼は穏やかに言います。En: "Try this; it will surely help," he said calmly.Ja: しかし、サクラは迷いました。En: However, Sakura hesitated.Ja: 彼女はまだ科学的な治療だけに頼りたい気持ちが残っていました。En: She still felt a lingering desire to rely solely on scientific treatments.Ja: ダイチはサクラの肩に手を置きました。En: Daichi placed a hand on Sakura's shoulder.Ja: 「時々、他の方法を試すことも大事だよ。En: "Sometimes, it's important to try other methods.Ja: 何より、君一人で頑張らなくてもいい」En: More than anything, you don't have to face this alone."Ja: その言葉で、サクラはようやく重い胸のうちを解放することができました。En: With those words, Sakura was finally able to release the heavy burden in her heart.Ja: 彼女はハルトの助けを受け入れ、またダイチに全てを打ち明けました。En: She accepted Haruto's help and confided everything to Daichi.Ja: 彼女の心は次第に軽くなっていきました。En: Her heart gradually began to lighten.Ja: 竹林の中の光が優しく二人を包む中、サクラはこれからは自分の健康を無視しないことを誓いました。En: As the gentle light within the bamboo grove enveloped them, Sakura vowed not to ignore her health anymore.Ja: そして、彼女は友達の大切さを再確認しました。En: She also reaffirmed the importance of friendship.Ja: 秋の終わり、嵐山はさらに美しく輝いていました。そして、 サクラの心もまた同じように輝き始めたのでした。En: By the end of autumn, Arashiyama was shining more beautifully than ever, and Sakura's heart began to shine in much the same way.Ja: 困難な中でも、一人で抱え込むことなく、支え合うことの大切さを知った日。それがサクラの新しい始まりでした。En: It was the day Sakura realized the importance of not bearing hardships alone, and supporting one another, marking a new beginning for her. Vocabulary Words:gently: 優しくbreeze: 風grove: 竹林adorned: 飾っていますpersistent: しんどいheadache: 頭痛outstanding: 素晴らしいworsened: 悪化しscholarship: 奨学金confiding: 打ち明けましたherbalist: 薬草師suggested: 提案しましたremedy: 薬herbs: 草hesitated: 迷いましたlingering: 残っていましたscientific: 科学的なtreatments: 治療enveloped: 包むvowed: 誓いましたignore: 無視するreaffirmed: 再確認しましたhardships: 困難supporting: 支え合うbeginning: 始まりequine: 秋分の日tears: 涙elderly: 年老いたburden: 重い胸のうちconfided: 打ち明けました

In this episode, we dive into one of the most significant housing policy changes in British Columbia's history: the Small Scale Multi-Unit Housing (SSMUH) legislation and the province-wide densification of single-family home lots - but this time, with 3 different Architectural firms. This is likely the largest rezoning initiative we'll witness in our lifetimes, and with such a massive shift comes a lot of uncertainty. What does this mean for housing affordability, development timelines, and the future of our cities?To help unpack these complex topics, we are joined by leading voices from three prominent architectural firms in BC, all members of the FIELD COLLECTIVE, a collaborative group of small architecture practices. Together, they will share their insights on the SSMUH initiative, its implications for housing design, and how their industry is responding to these new policies.Our guests today include Tony from TOAD Design, Jenny and David from 2 by 2, and Daichi from Bobo Arch. We'll hear about their personal journeys in architecture, as well as how their firms are navigating this new legislative landscape.One of the central issues of this conversation revolves around the province's recent introduction of pre-approved housing designs. These designs are intended to streamline the development process, cutting down on costly and lengthy permitting times. But will this initiative actually drive down housing costs? Or could it result in more uniform, less site-specific designs that lack creativity and adaptability? Tony, Jenny, David, and Daichi will explore whether these pre-approved models offer real solutions or if they're just another example of top-down policy lacking industry consultation.Finally, we'll get a preview of PLEX APPEAL, an open-air exhibition organized by the FIELD COLLECTIVE as part of the upcoming Design Vancouver Festival. This event will showcase innovative designs enabled by the new multiplex zoning rules, offering the public a firsthand look at what the future of housing in BC could look like.Tune in to this episode for an insightful conversation on one of the most pressing topics in housing today. Learn how the SSMUH legislation and pre-approved designs could reshape the real estate landscape, and gain valuable insights from some of the brightest minds in BC's architecture community. Plus, get all the details on PLEX APPEAL, and find out how you can attend this exciting event later this month!—  Plex Appeal ExhibitionSeptember 28 - 29, 2024Main & 21st Public Plazawww.plexappeal.ca—  Tony Osborn, Architect AIBC, MRAIC, LEED APTony Osborn Architecture + Design Inc.#203 - 119 W Pender St, Vancouver BC  V6B 1S5o 604 283 5877 x100m 604 363 3790tony@toad.design__ David TylArchitect AIBCCo-FounderTwobytwo Architecture Studiomobile: 604.317.7715david@twobytwo.cawww.twobytwo.caThe C4X project: www.twobytwo.ca/c4xInstagram: @twobytwostudio__ Daichi YamashitaArchitect AIBC | Passive House DesignerBobo Architecture | www.boboarch.ca604-440-1374instagram.com/bobo_architecture/  _________________________________ Contact Us To Book Your Private Consultation:

Haikyu! x Philippians 4:11Your daily crossover of faith and fandom! Experience daily Biblical encouragement from nerdy Christian podcasters, bloggers and content creators. Join the Nerd of Godcast community at www.NOGSquad.com

Fluent Fiction - Japanese: Rain-Soaked Beginnings: Art and Friendship in Shinjuku Gyoen Find the full episode transcript, vocabulary words, and more:fluentfiction.org/rain-soaked-beginnings-art-and-friendship-in-shinjuku-gyoen Story Transcript:Ja: 新宿御苑の夏の日、空は青く、草木は緑濃く、静かな美しさを放っていました。En: On a summer day in Shinjuku Gyoen, the sky was blue, the greenery was lush, and everything radiated a quiet beauty.Ja: 園内では、色とりどりの花が咲き誇り、人々は季節の美を楽しんでいました。En: Inside the garden, colorful flowers bloomed in abundance, and people enjoyed the beauty of the season.Ja: そこに、静かにスケッチをしている一人の女性、はるかがいました。En: There, a woman named Haruka sat quietly sketching.Ja: 彼女は内向的な芸術家で、祖先を敬うお盆の時期に平和とつながりを求めていました。En: An introverted artist, she sought peace and connection during the Obon period, a time to honor her ancestors.Ja: その傍らを通りかかるのは、だいちという青年でした。En: Passing by was a young man named Daichi.Ja: 彼は活気あふれる写真家で、この庭園で夏の伝統を写真に収めようとしていました。En: He was a lively photographer aiming to capture the summer traditions in this garden through his lens.Ja: 彼のカメラは、自然の美しさや人々の感情を捉えようと忙しく働いていました。En: His camera busily tried to capture the beauty of nature and the emotions of people.Ja: しかし、急に空が曇り始め、大粒の雨が降り出しました。En: Suddenly, the sky began to cloud over, and large drops of rain started to fall.Ja: 「大変だ、雨が降ってきた」とだいちは思いました。En: "Oh no, it's starting to rain," thought Daichi.Ja: そして、近くの東屋に急ぎ、雨宿りをすることにしました。En: He hurried to a nearby gazebo to take shelter.Ja: そこには、すでに雨を避けたはるかがいました。En: Haruka was already there, having taken refuge from the rain.Ja: 二人は黙って雨を見ながら時間を過ごしました。En: The two of them silently watched the rain together.Ja: だいちはやがて声をかけました。En: Eventually, Daichi spoke up.Ja: 「雨が止むまで少しお話しませんか？En: "Would you like to chat until the rain stops?"Ja: 」はるかは少し驚きましたが、彼のカメラを見て興味を持ち、スケッチブックを見せました。En: Haruka was slightly surprised but, intrigued by his camera, showed him her sketchbook.Ja: だいちは彼女の絵に感嘆し、「これを僕の写真プロジェクトに含められたら素敵だね」と言いました。En: Daichi was impressed by her artwork and said, "It would be wonderful if I could include this in my photography project."Ja: はるかは少し迷いましたが、だいちの情熱にひかれました。En: Haruka hesitated a bit but was drawn to Daichi's passion.Ja: 二人はアートと経験について語り合い、互いの視点を分かち合いました。En: The two shared their thoughts on art and experiences, exchanging perspectives.Ja: 雨の音に包まれながら、二人は心の交流を深めていきました。En: Wrapped in the sound of the rain, they deepened their connection.Ja: そして、雨がやみ、晴れた空が戻ると、二人は連絡先を交換し、再び会う約束をしました。En: When the rain stopped and the clear sky returned, they exchanged contact information and promised to meet again.Ja: はるかは新たな友人に心を開くことができ、だいちはゆっくりとした瞬間の価値を理解しました。En: Haruka was able to open her heart to a new friend, and Daichi came to appreciate the value of slow moments.Ja: 清められた空気の中で、彼らの友情はゆっくりと新たな一歩を踏み出しました。En: In the cleansed air, their friendship took a gentle new step forward.Ja: これからも二人は手を取り合い、美しい夏の思い出を作っていくことでしょう。En: Together, they would continue to create beautiful summer memories. Vocabulary Words:lush: 緑濃くradiated: 放っていましたabundance: 咲き誇りsketching: スケッチintroverted: 内向的なancestors: 祖先capture: 収めようlens: レンズcloud over: 空が曇りdrops: 大粒shelter: 雨宿りgazebo: 東屋refuge: 避けたintrigued: 興味を持ちsketchbook: スケッチブックhesitated: 迷いましたdrawn: ひかれましたperspectives: 視点wrapped: 包まれconnection: 心の交流cleansed: 清められたgentle: ゆっくりとstep forward: 新たな一歩memories: 思い出honor: 敬うtraditions: 伝統emotions: 感情impressed: 感嘆experiences: 経験appreciate: 理解しました

Raised in Shibuya, Tokyo and now calling Naarm/Melbourne home for the past year, Kamome cut his teeth playing adventurous extended sets as part of the Tokyo based Vinyl Youth DJ collective, with close mentorship from local legends KEITA SANO and Yamarchy from the notorious Shibuya small club, Mitsuki.
 Kamome brings his unique and playful musical stylings to the table for the latest episode with a mix as deep and immersive as it is quirky and acid-groovy, primed for late night smoky dancefloor indulgence! 

 @kamome-8787 Q. What inspiration did you draw upon when putting this mix together? Is there a sound, feeling, time or place that connects all the different elements in one way or another? A. The inspiration for this mix comes from my upcoming one year of being in Australia, and I created it with the hope that the local people will get to know me. As a Japanese person, this mix is largely composed with sounds from the Japanese community and those of my seniors and friends. Q. Are there any songs in the mix that are especially close to your heart, and what is it about these tracks that resonate with you so much? A. All the tracks in this mix by Chida, Keigo Okazaki, Daichi, Yamarchy, ifax!, Dj Himitsu, and KEITA SANO are important to me, but the one that stands out the most is the debut track "Got to be real" by DAICHI & Yamarchy, which will be released at the end of August. This edit seems to be a re-edit of a past track from the label Clue-L, run by Kenji Takimi. Q. I know you've featured some incredible unreleased Japanese records in this mix! What Japanese artists/labels are responsible for some of your favourite sounds of late, and who should we be watching out for? A. An artist I'm keeping an eye on is DAICHI, a member of my collective "Vinyl Youth." His recent release from MM Disco, based in Berlin and Barcelona, is still fresh in my memory, and I can't wait for what's next ! An artist to watch is KEITA SANO, and although not Japanese, Lunatic Music, based here in Melbourne, is also noteworthy. Keita is like an older brother to me :) and he releases works in a unique style at an incredible pace. (He has released five works this year alone.) Bart and Jack, who run Lunatic Music, have been invaluable friends since I came to Melbourne. Their label features Japanese artists, and all their releases are excellent. Be sure to check them out!

Crystal Palace signed Daichi Kamada from Lazio. Daichi Kamada is a Japanese professional footballer who plays as an attacking midfielder or a forward for Premier League club Crystal Palace and the Japan national team.

Fluent Fiction - Japanese: Journey to Confidence: Hina's Artistic Discovery in Santorini Find the full episode transcript, vocabulary words, and more:fluentfiction.org/journey-to-confidence-hinas-artistic-discovery-in-santorini Story Transcript:Ja: ギリシャの美しい島、サントリーニ。En: The beautiful Greek island of Santorini.Ja: 夏の日差しが白い建物を鮮やかに照らし、青い屋根が空と海の青と調和している。En: The summer sun vividly shines on the white buildings, with their blue roofs harmonizing with the blues of the sky and sea.Ja: ここには色とりどりの布地、陶器、手作りのジュエリーが並ぶ市場が広がっている。En: Here, a market spreads out, displaying colorful fabrics, pottery, and handmade jewelry.Ja: 市場の中を歩く人々の間には、香辛料や海の香りが漂っていた。En: Amidst the people walking through the market, the scents of spices and the sea wafted through the air.Ja: 「何か特別なものを見つけたい。」ヒナは言った。En: "I want to find something special," Hina said.Ja: 彼女は東京での次のアート展覧会のために、インスピレーションを求めていた。En: She was seeking inspiration for her next art exhibition in Tokyo.Ja: ダイチはヒナのそばに立ち、賢く現実的な意見を述べるのが常だった。En: Daichi always stood by her side, offering wise and practical opinions.Ja: 今日は同じだった。En: Today was no different.Ja: 「ヒナ、時間を無駄にしているよ。En: "Hina, you're wasting time.Ja: どんどん見て回って、早く決めよう。」とダイチはせかした。En: Let's keep looking and decide quickly," Daichi urged.Ja: そのとき、魅力的な笑顔を持つアキラという名の地元の商人が現れた。En: At that moment, a local merchant named Akira, with a charming smile, appeared.Ja: 「こんにちは、お二人さん。En: "Hello, you two.Ja: 何かお探しですか？」アキラは親しみやすい口調で話しかけてきた。En: Are you looking for something?" Akira spoke in a friendly tone.Ja: 「この市場にはたくさんの珍しい物がありますよ。」En: "There are many rare items in this market."Ja: 「私はただ、ユニークでオーセンティックなものを探しています。」ヒナは説明した。En: "I'm just looking for something unique and authentic," Hina explained.Ja: 「でも、偽物や高すぎるものが多くて。」En: "But there are so many fakes and overpriced items."Ja: アキラは微笑んだ。En: Akira smiled.Ja: 「わかりました。En: "I understand.Ja: こちらに来てください、特別な品物を見せましょう。」En: Please come this way; I have some special items to show you."Ja: アキラの案内で進むと、ヒナは美しい壺を見つけた。En: Following Akira's lead, Hina found a beautiful jar.Ja: それはとても繊細で、ほかでは見つからないほど特別なものであった。En: It was so delicate and unique that it stood out like nothing else.Ja: 「これだ！」とヒナは思った。En: "This is it!" Hina thought.Ja: 「これが私の作品にぴったりだ。」En: "This is perfect for my work."Ja: しかし、アキラは突然「価格が少し高くなります。この壺は特別ですから。」と言い、値段を上げた。En: However, Akira suddenly said, "The price is slightly higher because this jar is special," and raised the price.Ja: 「ちょっと待ってくださいよ！」ダイチは抗議した。En: "Wait just a minute!" Daichi protested.Ja: 「これはぼったくりだ！」En: "This is a rip-off!"Ja: ヒナは心の中で葛藤した。En: Hina struggled internally.Ja: アキラの意図は何なのか、信じられるのか。En: What were Akira's true intentions?Ja: 信じられるのか。En: Could he be trusted?Ja: ダイチの言う通り、早く決めるべきか。En: Should she decide quickly as Daichi suggested?Ja: そして、自分の本能を信じてよいのだろうか。En: And could she trust her own instincts?Ja: 「私はこの壺が好きです。En: "I like this jar.Ja: でも、価格について交渉させてください。」ヒナはアキラに向かって毅然と言った。En: But let me negotiate the price," Hina said to Akira firmly.Ja: アキラは一瞬驚いた表情を見せたが、次の瞬間微笑み、「分かりました、ヒナさん。En: Akira showed a surprised look for a moment but then smiled and said, "Understood, Hina.Ja: 特別価格で譲りましょう。」と答えた。En: I'll give it to you at a special price."Ja: ヒナは壺を手にいれ、胸が温かくなった。En: With the jar in hand, Hina felt warmth in her chest.Ja: それは単なる物体以上のもので、彼女の自信の象徴でもあった。En: It was more than just an object; it was a symbol of her newfound confidence.Ja: 「よくやったよ、ヒナ。」ダイチは誇らしげに言った。En: "Well done, Hina," Daichi said proudly.Ja: ヒナは笑顔で答えた。「これからは、自分の直感を信じるわ。En: Hina replied with a smile, "From now on, I'll trust my instincts.Ja: ダイチの助けも、もちろんありがとう。」En: Thank you for your help too, Daichi."Ja: 市場を後にする二人の後ろで、アキラは静かに微笑んでいた。En: As the two left the market, Akira quietly smiled behind them.Ja: このエピソードが彼にとっても特別な意味を持ったのかもしれない。En: Perhaps this episode held special meaning for him as well.Ja: そして、ヒナはサントリーニの市場で得た壺と思い出を胸に、次のアート展覧会を迎える準備を進めたのであった。En: And so, with the jar and memories from the Santorini market in her heart, Hina prepared for her next art exhibition. Vocabulary Words:vividly: 鮮やかにharmonizing: 調和しているdisplays: 並ぶfabrics: 布地pottery: 陶器handmade: 手作りscents: 香りwafted: 漂っていたinspiration: インスピレーションexhibition: 展覧会practical: 現実的merchant: 商人charming: 魅力的unique: ユニークauthentic: オーセンティックraised: 上げたrip-off: ぼったくりprotested: 抗議したstruggled: 葛藤したintentions: 意図instincts: 本能negotiate: 交渉するfirmly: 毅然とconfidence: 自信episode: エピソードsymbol: 象徴proudly: 誇らしげair: 空warmth: 温かさmemories: 思い出

Crystal Palace have completed the signing of Japan international Daichi Kamada on a two-year deal, subject to international clearance.This podcast has been created by Back of the Nest. The views in this podcast are not necessarily the views of talkSPORT.Support this show http://supporter.acast.com/holmesdaleradio. Become a member at https://plus.acast.com/s/holmesdaleradio. Hosted on Acast. See acast.com/privacy for more information.

OFFICIAL Daichi Kamada Announcement #cpfc #crystalpalaceLink to article:https://www.cpfc.co.uk/news/club/incredible-intelligence-work-rate-daichi-kamada-analysed-ben-mabley/Become a supporter of this podcast: https://www.spreaker.com/podcast/palace-to-the-core-crystal-palace-pod--5084265/support.

Fluent Fiction - Japanese: Mysteries of Tanabata: The Night Hoshikage Village Found Peace Find the full episode transcript, vocabulary words, and more:fluentfiction.org/mysteries-of-tanabata-the-night-hoshikage-village-found-peace Story Transcript:Ja: 夏の夜、星が輝く空の下、村は賑やかだった。En: On a summer night, under a sky sparkling with stars, the village was bustling with activity.Ja: 今日は七夕祭り。En: Today was the Tanabata Festival.Ja: 色とりどりの短冊が竹に飾られ、村人たちは浴衣を着て神社に集まっていた。En: Multicolored strips of paper hung on bamboo, and the villagers, dressed in yukata, gathered at the shrine.Ja: この村の名前は「星影村」。En: This village's name was "Hoshikage Village."Ja: 山奥にひっそりと佇む神社、その名前は「星影神社」。En: Secluded deep in the mountains stood a shrine, named "Hoshikage Shrine."Ja: この神社には古い伝説があった。En: This shrine had an ancient legend.Ja: 光（ひかる）は十五歳。En: Hikaru was fifteen years old.Ja: 地元の伝説に興味があり、村の秘密を探るのが好きだった。En: He was interested in local legends and loved exploring the village's secrets.Ja: 妹の由奈（ゆな）は賢くて、時々兄を小馬鹿にする。En: His sister Yuna was smart and occasionally made fun of her brother.Ja: 一方、村の長老である大地（だいち）は多くの秘密を持っている。En: Meanwhile, Daichi, the village elder, held many secrets.Ja: 七夕祭りの夜、村はいつも不思議な空気に包まれていた。En: On the night of the Tanabata Festival, the village was always enveloped in a mysterious atmosphere.Ja: 今年も同じだ。En: This year was no different.Ja: 光は、去年の祭りで一人の若者が神社付近で消えたことを覚えていた。En: Hikaru remembered that a young man had disappeared near the shrine during last year's festival.Ja: そんな彼を村人たちは警告した。「あの神社には近づくな」と。En: The villagers had warned him, "Don't get close to that shrine."Ja: しかし、光は気になって仕方がなかった。En: However, Hikaru couldn't help but be curious.Ja: 「由奈、今年も誰かが消えるのかな？」光は祭りの人混みを見ながら妹に言った。En: "Yuna, do you think someone will disappear again this year?" Hikaru asked his sister, looking at the bustling crowd.Ja: 「バカね、そんなのただの噂よ。」由奈はため息をついた。En: "You're silly, that's just a rumor," Yuna sighed.Ja: しかし、光は諦めず、神社の方へ向かった。En: Still, Hikaru was persistent and headed toward the shrine.Ja: 古い鳥居をくぐり、苔むした小道を歩いていく。En: He passed through the old torii gate and walked along the moss-covered path.Ja: 心臓が早く打ち始める。En: His heart began to beat faster.Ja: やがて、神社の本殿に着いた。En: Eventually, he reached the main hall of the shrine.Ja: そこには冷たい風が吹き抜け、背筋がゾクッとした。En: A cold wind blew through, sending a chill down his spine.Ja: 「何か感じる？」光は神社の隅々まで調べた。En: "Do you feel anything?" Hikaru inspected every corner of the shrine.Ja: その時、突然、古い扉の奥から音がした。En: At that moment, a sound came from behind an old door.Ja: 光は躊躇せず扉を開けた。En: Without hesitation, Hikaru opened the door.Ja: 暗い部屋の中には、古い壁画が描かれていた。En: Inside the dark room, there were ancient murals.Ja: 壁画には、毎年七夕の夜に現れる妖怪が描かれていた。その妖怪は祭りの最中に若者をさらっていたのだ。En: The murals depicted a yokai that appeared every year on the night of Tanabata, abducting young people during the festival.Ja: 「信じられない…」光は呆然とした。En: "I can't believe it…" Hikaru stood in shock.Ja: その時、大地が現れた。En: Just then, Daichi appeared.Ja: 彼の顔は悲しみに満ちていた。En: His face was filled with sorrow.Ja: 「もうやめるんだ、光。これは我々の過去だ。」と大地が語り始めた。En: "Stop it, Hikaru. This is our past," Daichi began to speak.Ja: 大地は、昔、この村で妖怪に対抗するために神社を建てたことを話した。En: Daichi explained that long ago, the shrine was built to oppose the yokai that threatened the village.Ja: そして、毎年一人が犠牲となることで村が守られてきたと告白した。En: He confessed that every year, one person was sacrificed to protect the village.Ja: 由奈も驚いていた。En: Yuna was also astonished.Ja: 「でも、もうそんなことは終わりにしよう。」光は強く言った。En: "But let's put an end to this," Hikaru said firmly.Ja: 「分かった。もう終わりにしよう。」大地はついに決心した。En: "Alright. Let's end it," Daichi finally made up his mind.Ja: その夜、光と由奈、大地は神社の奥の部屋に封印を施した。妖怪が二度と現れないように。En: That night, Hikaru, Yuna, and Daichi sealed the room deep inside the shrine so the yokai could never appear again.Ja: そして、その瞬間、星がさらに輝き、村は静けさを取り戻した。En: At that moment, the stars shone even brighter, and the village regained its tranquility.Ja: その後、光は村の伝統をもっと尊重し、由奈も兄の直感を信じるようになった。En: Afterward, Hikaru came to respect the village's traditions more, and Yuna began to trust her brother's intuition.Ja: 星影村の七夕祭りは、再び平和に戻った。En: The Tanabata Festival in Hoshikage Village returned to peace.Ja: 「ありがとう、光。」村人たちは感謝の気持ちでいっぱいだった。En: "Thank you, Hikaru." The villagers were filled with gratitude.Ja: こうして、星影村の夏が再び穏やかに訪れた。En: Thus, the summer in Hoshikage Village returned to its serene state.Ja: 光と由奈の絆も、以前よりずっと深く強くなったのだった。En: The bond between Hikaru and Yuna grew deeper and stronger than before. Vocabulary Words:bustling: 賑やかmulticolored: 色とりどりgathered: 集まってsecluded: ひっそりとlegend: 伝説exploring: 探るのが好きmysterious: 不思議なenveloped: 包まれていたdisappeared: 消えたwarned: 警告したrumor: 噂persistent: 諦めずtorii gate: 鳥居moss-covered: 苔むしたmain hall: 本殿chill: ゾクッとしたinspected: 調べたmurals: 壁画depicted: 描かれていたabducting: さらってshock: 呆然としたsorrow: 悲しみにsacrificed: 犠牲confessed: 告白したopposed: 対抗intuition: 直感sealing: 封印tranquility: 静けさserene: 穏やかbond: 絆

Daichi Kamada Announcement Date Plus Eze Transfer News #cpfc #crystalpalace Become a supporter of this podcast: https://www.spreaker.com/podcast/palace-to-the-core-crystal-palace-pod--5084265/support.

Daichi Kamada To Have Medical With Crystal Palace Plus England Performances #cpfc #crystalpalaceBecome a supporter of this podcast: https://www.spreaker.com/podcast/palace-to-the-core-crystal-palace-pod--5084265/support.

Daichi Kamada Transfer Twist #cpfc #crystalpalaceBecome a supporter of this podcast: https://www.spreaker.com/podcast/palace-to-the-core-crystal-palace-pod--5084265/support.

I'll never forget the first time I heard a ghost story that made the hairs on the back of my neck stand up. It was a tale not unlike Midori's, filled with betrayal, revenge, and the supernatural. Our latest episode whispers the chilling legend into your ears, taking you through the shadowy ruins of a love that spiraled into darkness. We explore the tragic story of Midori, the forsaken wife of a samurai whose discovery of his betrayal ignites a horrifying chain of events. Her spirit, now a vengeful yurei, remains shackled to the remnants of her past, her very presence a harbinger of doom. You'll walk alongside Daichi, a young man mesmerized by the occult, who unexpectedly finds himself face-to-face with Midori's ghost, embroiling him—and everyone around him—in her relentless thirst for retribution. But among the whispers of the past and the echoes of sorrow, there's a glimmer of hope.Join us as we recount Daichi's courageous venture into the unknown to pacify the turbulent soul of Midori. Through rituals steeped in ancient wisdom and the silent power of empathy, he embarks on a journey to offer respite to the vengeful spirit. Feel the weight of the night lift as sacred prayers and the scent of incense mark the transformation of a once tormented phantom into a being of tranquility. Experience the poignant moment of release as Midori acknowledges his endeavors, closing the chapter of her haunting and granting peace to the living and the dead. This tale is not just a ghost story—it's a testament to the enduring human spirit and its capacity to heal the deepest of wounds.

Lazio's 1-0 win over Genoa came thanks to a goal made by two players with uncertain futures: Daichi Kamada and Luis Alberto. Vittorio and Alasdair discuss what the future holds for the two, look ahead to Tuesday's Coppa Italia semi-final second leg against Juventus, and consider the run-in to the Champions League race.

今日ピックアップするのは44位に初登場、MINA OKABE FEAT. DAICHI YAMAMOTO「FLASHBACK」MINA OKABEといえば8月にJ-WAVE「SONAR TRAX」に選ばれた「EVERY SECOND」がヒット。9月にLOCA GREEN FESTIVALのため、来日していました。今回の楽曲「FLASHBACK」は、10月9日にスタートしたフジテレビ系 月9ドラマ「ONE DAY～聖夜のから騒ぎ～」の主題歌となっていて、プロデュースは小袋成彬が手がけています。

Drs. Vamsi Velcheti, Taofeek Owonikoko, and Janakiraman Subramanian discuss their experiences navigating the cancer drug shortage in the United States, the impact on patients and clinical trial enrollment, lessons learned, and proactive strategies to mitigate future crises. TRANSCRIPT  Dr. Vamsi Velcheti: Hello, I'm Dr. Vamsi Velcheti, your guest host for the ASCO Daily News Podcast today. I'm a professor of medicine and director of thoracic oncology at the Perlmutter Cancer Center at NYU Langone. On today's episode, we'll be discussing the impact of the shortage of cancer chemotherapy drugs across the United States. This has been affecting several thousands of patients with adult and pediatric cancers and hampering enrollment in clinical trials. Among the shortages are very commonly used drugs like cisplatin, carboplatin, methotrexate, and fludarabine. Some of these shortages have persisted since the time of the pandemic in 2020.   So today, to discuss this really troubling scenario, I have two outstanding colleagues, Dr. Janakiraman Subramanian, the director of thoracic oncology at Inova Schar Cancer Institute in Virginia, and Dr. Taofeek Owonikoko, a professor of medicine and the chief of the Division of Hematology and Oncology at the University of Pittsburgh Hillman Cancer Center in Pittsburgh.   Our full disclosures are available in the transcript of this episode, and disclosures relating to all episodes of the podcast are available at asco.org/DNpod.  So, a recent survey by the NCCN found that 90% of the nation's largest cancer centers have experienced a shortage in carboplatin, and 70% of the centers have reported a shortage in cisplatin. These are platinum-based chemotherapies we use frequently in patients with cancer, and these are often curative intent treatments for several cancers, and these are used in several tumor types, both solid tumors and hematologic malignancies. So, the scale of the problem is immense.   Dr. Owonikoko, I'd like to hear your take on this situation and how are you dealing with this at the UPMC Cancer Center.  Dr. Taofeek Owonikoko: Yeah, thank you, Dr. Velcheti, and happy to be part of this panel. As you rightly surmised, the chemotherapy drug shortage is what we've all experienced across the length and breadth of the United States. Our cancer center here in Pittsburgh is not an exception. We've had to be proactive as well as think outside the box to be able to manage the challenge. Just like every other cancer center across the country, maybe to varying degrees, we've had to look at patients in need of chemotherapy with these standard-of-care agents such as cisplatin or carboplatin, and to some degree docetaxel, during this past episode of drug shortage that we all went through. And while we did not have to, fortunately, cancel any patient treatment, we all went through it with bated breath; not sure of where the next batch of chemotherapy drugs will come through, but I would say in the past couple of weeks, we've actually seen some improvement in drug availability.   But before then, we've had to have contingency plans where, on a weekly basis, we review our patient list and the drug regimens that they're going to need, and must make sure that we have enough drug on hand for those patients. And in situations where we thought we might not have enough drug; we also had a plan to use alternative regimens. We were proactive in having guiding principles that are consistent with ASCO's recommendations in terms of quality care delivery for cancer patients. So, I'm sure that this is more or less the same approach adopted by other leading cancer centers across the country.   Dr. Vamsi Velcheti: Thank you, Dr. Owonikoko. And Dr. Subramanian, you're in a community setting, a large cancer center that serves a lot of patients in the state of Virginia. So, what is the scale of the problem at your institution and how are you handling it?   Dr. Janakiraman Subramanian: First of all, Dr. Velcheti, thanks for having me here on this panel. And as you rightly said, this is a significant problem, and it is across the country like Dr. Owonikoko said. And as medical oncologists, we are not always thinking of drug shortages. Our focus is on taking care of our patients. So, this is one more issue that we need to keep in mind now as we manage our patients with cancer. When this shortage started, the biggest problem, as you know, was when we became aware of this was primarily in cisplatin and we had some of our patients who were getting curative treatment and we had to make a decision - can they get cisplatin or can they get carboplatin. And one of the things we did was to have an ethics committee that will review each patient that is being planned to receive cisplatin-based chemotherapy and come to a decision on how best we can support them.   The template for some of this was based upon some of the triage mechanisms we used during COVID, as well as the ASCO guideline document for managing this chemotherapy shortage, which was one of the blueprints we used. And they have reviewed all cases, all patients that are being planned for cisplatin or carboplatin for that matter, and we come to a decision based on that. And we also have another committee that constantly monitors drug availability on a weekly basis and tries to forecast where the next problem would be as we take care of our patients.   And particularly as a lung cancer doctor, we've had situations where we had to use carboplatin instead of cisplatin and even we also have carboplatin shortage. And so, the committee usually approves two cycles at a time, but thankfully so far we have not had a situation where we could not offer our patients the chemotherapy treatment. But we are very carefully monitoring the situation, hoping that this will improve.   The other aspect of the shortage has been in 5FU. A lot of our GI colleagues; I treat esophageal cancer patients as well, where we've had to forego the bolus 5FU and have a 10% reduction on all 5FU infusions. And we've been using some of that dose reduction to ensure that we can have 5FU available for all our patients. And that's how we've been trying to manage this shortage situation here at Inova Schar.   Dr. Vamsi Velcheti: Dr. Subramanian and Dr. Owonikoko, we are oncologists, we are treating patients, and the toughest part really is telling a patient that we don't have access to certain drugs and we have to switch treatments to perhaps another treatment regimen that may be suboptimal. And it's always a very anxiety-provoking discussion, and especially for patients with metastatic cancer, they're already under a lot of stress and it's a really difficult conversation. How do you handle that, Dr. Owonikoko?  Dr. Taofeek Owonikoko: That's a conversation we all hope we don't have to have. And fortunately, with this current crisis, I've actually not had such misfortune of having to inform a patient that we don't have drugs to treat them or that we have to switch to something inferior. But conceptually, it's possible that could have happened and that would have been very difficult. But the one thing that we did, though, as part of our mitigation strategy was actually to inform the patient ahead of time because the way we handled this was to look at our inventory on a week-by-week basis. And if there are patients where we felt maybe they will be coming in towards the end of the week and we may not have enough drugs for them, to let them know the possibility exists that we might have to switch them to something different. While we did not have to do that for any patient, yes, there are patients that we had to give that heads up to, to say, “We're having this shortage. We're doing everything we can to make sure it's available. But just in case it's not available…” I think what is most important for most patients is to be aware of that decision ahead of time, to be able to process it, and to be transparent.   The other challenge that we face was, if you have to choose between patients, what should be your guiding principles as to who gets the drug and who doesn't get it? I think it's very easy for all of us to say, “Oh, if it's curative intent, we do it. If it's not curative intent, we don't do it.” It's a little more complicated than that because if we put the equity hat on, curative intent doesn't actually mean that that life is more valuable than somebody who cannot be cured. And this is where really, I think having people with expertise in ethics of care delivery and disaster management will be very important for us to proactively anticipate that, should this become a recurrent problem in the future that we actually have a well-vetted approach, just like we did during COVID where you have to ration resources that we have those people with expertise to help us as oncologists because not all of us, at least personally I can speak for myself, that is not my area of expertise and comfort.  Dr. Vamsi Velcheti: Excellent points. Dr. Subramanian, anything to add?  Dr. Janakiraman Subramanian: Oh, absolutely. I echo what Dr. Owonikoko said. These are conversations that we would like to hopefully never have with our patients. But this is a crisis that we are facing now. And personally, I can tell you two situations where we ran into this problem. But overall, though, we never had to stop a treatment or cancel a treatment for our patient. In the first situation, we had a young man with a rare germ cell tumor in the hospital for whom cisplatin was key. He was already in the ICU and sometimes the treatment start dates are not perfect, unlike what we do in the outpatient setting, depending on how well he's doing or the treatment start dates might move by a day or so. So we basically had to hold a certain dose of cisplatin for him.   This brings the next question, which is how do we decide who gets cisplatin versus who can go for an alternative option? And I think Dr. Owonikoko made a great point where, just because it is a curative disease does not mean their life is more valuable. This is where I think trying to make that decision at an individual level, as an individual treating physician can be extremely hard. And that's why at our institution we have this ethics committee where we have oncologists, pharmacists, and ethicists that review these chemotherapy orders, particularly for cisplatin, and try to use some guiding principles that we learned from COVID as well as ASCO's guidance to decide how we assign our resources. That's one option, one way we have done it.    And then in another situation that was faced by one of my GI oncology colleagues was a patient that was originally planned to go on a clinical trial where the chemotherapy backbone was FOLFOX and because we had the 5FU shortage, we could not offer that patient clinical trial enrollment. And that was a tough conversation where they had to tell them that they could not go on a clinical trial that they were looking forward to. And this then brings the next question, which is by foregoing the bolus 5FU and by the 10% reduction in the infusional 5FU, are we providing them inferior treatment? And it's a conversation that's had at a very individual level. I don't envy my colleague who had to have that conversation. It's a challenge and we try to do our best to communicate to our patients that we are trying to provide care without trying to compromise the effectiveness of treatment for them.  Dr. Vamsi Velcheti: Thank you so much both of you. And we had the same issues here at NYU in New York City as well. It appears, you know, the degree of shortage and the drugs that are in shortage has been somewhat different at different locations across the United States. But the theme has been that we are having to ration treatments for our patients. And of course, there are some tumor types where there's really no adequate substitution, for example, GU cancers. I mean, you can't really not give them cisplatin. A lot of these are situations which have curative intent and young patients. So, it's really troubling.   And I think one of the things that really came out of this is there's been a lot of push from professional societies that actually ASCO has been spearheading and some intense discussions with CMS and legislators to kind of provide more long-term fix for these things. And I think all of us have to be more engaged in those discussions with our professional societies like ASCO to kind of help promote awareness. So if you kind of think about it, these drugs are not that expensive. These are generic drugs that we've all been using for such a long time. And the fact that we can't provide these drugs for various reasons is kind of really concerning. We spend so much money on research and more expensive drugs and not being able to manufacture these drugs within the country and kind of having to rely on complex supply chains is troubling, and I hope the situation improves very soon.    So, I know both of you are at large cancer centers that enroll patients on clinical trials. Of course, these drugs, especially carboplatin, for lung cancer, especially, are like core treatments that are used in managing cancer patients with lung cancer. So how is this affecting your clinical trial accrual? Are you prioritizing patients on clinical trials for these drugs? Have you had to make any decisions to hold clinical trial accrual for certain trials? Kind of curious to hear.  Dr. Taofeek Owonikoko: Yeah, so I can maybe weigh in a little bit on that in terms of what we've had to do for patients receiving treatment as standard of care versus those going on clinical trials. As we all recognize that when a patient goes on a clinical trial, even if they are going to receive a standard-of-care regimen as part of that trial, it still has to be administered in line with the protocol. So, during the extreme period of shortage anxiety, we actually had consideration for perhaps not putting patients on trial if we're not sure that they will be able to continue to receive the protocol-mandated treatment, whether it's a control intervention or the experimental intervention.   The good thing to come out of this is at least here at UPMC, we actually did not have any instance where we had to deny a patient clinical trial participation. But there were anxious periods when we already had patients enrolled and they were scheduled to receive a platinum-containing regimen and we were not sure whether or not we were going to have adequate supply of the drug for them while on trial. I think this really raises an important consideration going forward as we come out of this current shortage. I don't by any stretch of the imagination assume that this is going to be the last one we experience, but I think the lessons learned here, we have to also carry that forward both in the design of the trial as well as in the regulatory environment surrounding clinical trial conduct, to say, should another incidence of drug shortage are to happen, how do we actually operationalize that with respect to patients on trial, whether starting or already on trial?   I think it's much more challenging when the patient is already on the trial, they've already started. It's less challenging if you just have to make a decision about somebody starting newly on the trial. But equally important is that by not allowing new patients to go on trial is denying something that potentially could be of benefit to them, albeit it is still a trial, it's not an established treatment option yet.  Dr. Janakiraman Subramanian : I completely agree with Dr. Owonikoko. Those were very key points and issues that we face as well. In terms of my patients with lung cancer, we haven't had a problem in getting them on clinical trials. Even though we have had carboplatin shortage patients who are already on treatment, they were able to get the carboplatin. For new patients, we were still able to provide them carboplatin as well. The biggest problem for clinical trials has been primarily with my GI colleagues who have to use 5FU. And there, as I said before, we are unable to give bolus 5FU and there is a 10% reduction of the infusional 5FU. So, we can't have any of these patients go on clinical trials.    And as a result, anything that has to do with 5FU has come to a screeching halt in terms of clinical trials for our patients. And I think I echo the point of Dr. Owonikoko that by no means this is the last drug shortage we're going to be dealing with and we are here today discussing this, also because this shortage has not ended. It's been ongoing. It's one of the longest drug shortages in my memory as a medical oncologist, and that's concerning. We still see that there is some improvement, but we haven't gotten past it yet.     And therefore, as we develop clinical trials and we need to have methods to address drug shortages and how we manage patient enrollment as well as how do we manage existing patients who are already on a clinical trial and, if possible, what might be their options in that situation. We may not have all the answers, but it is definitely an issue that we need to think about in the future as we develop and implement newer clinical trials for our patients.  Dr. Vamsi Velcheti: I completely agree and great points, both of you. And we've had the same issues with clinical trials at NYU Langone as well due to the shortage. It's been a challenge, and I think this is a problem that's so complex because of supply chain issues and the way the drugs are priced and incentives for manufacturing these drugs in the United States are not lucrative enough to actually onshore a lot of the production of these drugs.   I think at the end of the day, I think we have to come up with some creative, innovative, reimbursement structures for these generic chemotherapy drugs. I think this would require a very complex economic solution that perhaps ASCO and other organizations should kind of really foster an environment of innovation to kind of help facilitate onshoring some of the manufacturing of these key drugs within the United States. I think ASCO is already trying to do that, trying to collaborate with all the stakeholders to kind of address this problem is very critical, and I think all of us have to be engaged in some of the advocacy efforts that are ongoing to kind of address these drug shortages. And this is not a short-term problem.  So, Dr. Owonikoko and Dr. Subramanian, any final thoughts before we wrap up the podcast today?  Dr. Janakiraman Subramanian: So, Vamsi, you mentioned the whole complex supply chain and the fact that we rely primarily on overseas manufacturers to get these drugs that are off-patent but still a key backbone of our cancer treatment. I think those are all key issues that policymakers and leaders in the field have to keep in mind. As an institution at Inova, one of the key mechanisms that have helped us to sort of stay ahead of the shortage was to have this inventory management team that monitors the inventory out there. And in fact, the inventory management team does have access to what the inventory is in some of their main suppliers in terms of the drugs. And they also have an idea of how many patients are going through treatment, what is the weekly usage of a specific drug like carboplatin. And they try to forecast what is coming down the road and try to prepare for it.   And as we try to look for solutions, maybe a forecasting mechanism in a larger scale like either spearheaded by ASCO or by policymakers level that can, for the overall country, try to see where some of the inventory is for some of these critical drugs and try to prepare for it ahead of time, rather than wait till we hit the shortage and then try to find alternative suppliers to get the drug, which obviously doesn't happen quick enough. It takes months or even longer to catch up and get the inventory back to the level where we can comfortably take care of our patients.  I think that is something we should be advocating for that as well as the professional societies should take a handle on that and see if they can support something like that as well as letting the institutions know ahead of time what's coming might be very helpful.  Dr. Vamsi Velcheti: Yeah, very good point, Janakiraman, and I think that's a key takeaway here. I think we have to learn from other industries and try to– I mean this is not unique to healthcare by any means. I mean these chronic shortages due to supply chain issues, inventory management, there might be some learnings from other industries here that we probably should also focus on inventory management and improve supply chain logistics.   Dr. Owonikoko, any closing thoughts?   Dr. Taofeek Owonikoko: Yeah, I agree as well with all the points made by Dr. Subramanian and yourself. This is a chronic problem that requires a long-term strategy. I think it's both an economic problem as well as a regulatory problem. As we all know, part of the reason why we went through this current crisis is the regulatory decision by the FDA regarding safety of one of the manufacturers. So being proactive in terms of how these audits are conducted and giving people lead time I think will help avoid similar situations in the future.    It's an economic problem. There's a reason why a lot of the big pharma companies are not producing these drugs. And if the cost of production is such that the amount of money you get paid is enough to cover your price, I think there is an economic issue there to be addressed. That is unfortunately not within the scope of what any one of us can do individually, but as advocates in terms of the structure of incentivizing new drug versus old drug, some of these newer drugs are quite expensive, but oftentimes they are used along with standard drugs that are not as expensive. So, where do we strike that balance where we do not stifle innovation but at the same time, we don't create a perverse incentive system where everybody just wants to come up with the newest, most expensive drug and nobody is interested in really producing the backbone chemotherapy and other agents that will make those new drugs work well.   So, I think we have to pay attention. We have to advocate for our patients through our different institutions and organizations, and I hope that society as a whole that we've learned a lot of lessons from this crisis and that will help us craft some long-term strategies.   Dr. Vamsi Velcheti: Thank you both Dr. Owonikoko and Dr. Subramanian for your time today to speak with me and our listeners and for sharing your insights with us on the ASCO Daily News podcast.   Dr. Taofeek Owonikoko: Thank you.   Dr. Janakiraman Subramanian: Thank you.  Dr. Vamsi Velcheti: And thank you to our listeners for your time today. If you value the insights that you hear on ASCO Daily News Podcast, please take a moment to rate, review and subscribe wherever you get your podcast. Thank you so much.  Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.  ASCO Resources Related to Drug Shortages are available here.     Follow today's speakers:    Dr. Vamsidhar Velcheti    @VamsiVelcheti    Dr. Janakiraman Subramanian  @RamSubraMD  Dr. Taofeek Owonikoko  @teekayowo    Follow ASCO on social media:     @ASCO on X (formerly Twitter)    ASCO on Facebook    ASCO on LinkedIn      Disclosures:     Dr. Vamsidhar Velcheti:     Honoraria: ITeos Therapeutics    Consulting or Advisory Role: Bristol-Myers Squibb, Merck, Foundation Medicine, AstraZeneca/MedImmune, Novartis, Lilly, EMD Serono, GSK, Amgen, Elevation Oncology, Taiho Oncology, Merus    Research Funding (Inst.): Genentech, Trovagene, Eisai, OncoPlex Diagnostics, Alkermes, NantOmics, Genoptix, Altor BioScience, Merck, Bristol-Myers Squibb, Atreca, Heat Biologics, Leap Therapeutics, RSIP Vision, GlaxoSmithKline      Dr. Janakiraman Subramanian:  Consulting or Advisory Role: AstraZeneca, Boehringer Ingelheim, Pfizer, Novartis, Daichi, G1 Therapeutics, Jazz Pharmaceuticals, Janssen Oncology, Lilly, Blueprint Medicines, Axcess, BeiGene, Cardinal Health, Takeda, OncoCyte  Speakers' Bureau: AstraZeneca, Boehringer Ingelheim, G1 Therapeutics, Jazz Pharmaceuticals, Janssen Oncology  Research Funding (Inst.): G1 Therapeutics, Tesaro/GSK, Novartis, Genentech, Novocure, Merck   Dr. Taofeek Owonikoko:  Stocks and Other Ownership Interests: Cambium Oncology, GenCart, Coherus Biosciences  Consulting or Advisory Role: Novartis, Celgene, Abbvie, Eisai, GI Therapeutics, Takeda, Bristol-Myers Squibb, MedImmune, BerGenBio, Lilly, Amgen, AstraZeneca, PharmaMar, Boehringer Ingelheim, EMD Serono, Xcovery, Bayer, Merck, Jazz Pharmaceuticals, Zentalis, Wells Fargo, Ipsen, Roche/Genentech, Janssen, Exelixis, BeiGene, Triptych Health Partners, Daichi, Coherus Biosciences  Speakers Bureau: Abbvie  Research Funding (Inst.): Novartis, Astellas Pharma, Bayer, Regeneron, AstraZenece/MedImmune, Abbvie, G1Therapeutics, Bristol-Myers Squibb, United Therapeutics, Amgen, Loxo/Lilly, Fujifilm, Pfizer, Aeglea Biotherapeutics, Incyte, Merck, Oncorus, Ispen, GlaxoSmithKline, Calithera Biosciences, Eisai, WindMIL, Turning Point Therapeutics, Roche/Genentech, Mersana, Meryx, Boehringer Ingelheim  Patents, Royalties, Other Intellectual Property (Inst.):   Overcoming Acquired Resistance to Chemotherapy Treatments Through Suppression of STAT3  Selective Chemotherapy Treatments and Diagnostic Methods Related Thereto  DR4 Modulation and Its Implications in EGFR-Target Cancer Therapy Ref: 18089 PROV (CSP) United States Patent Application No. 62/670,210 June 26, 2018 (Co-Inventor)  Soluble FAS ligand as a biomarker of recurrence in thyroid cancer; provisional patent 61/727,519 (Inventor)  Other Relationship: Roche/Genentech, EMD Serono, Novartis  Uncompensated Relationships: Reflexion Medical           

Alina finally learns the truth of what's going on in the park. Will she agree with it? Or will she form her own destiny?CREDITS: Residents of Proserpina Park is a production written and produced by Angela Yih. Directed by Angela Yih. The voice of Mirai is Vida Shi. The voice of Terry is Molly. The voice of Jessica is Jess Syratt. The voice of Sam is G3. The voice of the Jinn is Ahmad "AJ" Joudeh. The voice of Alina is Angela Yih. The voice of Dog is Sara Roncero-Menendez. The voice of Jun is Ben Pollizi. The voice of Drew is Ashley Dawson. The voice of the Creature is Nick Fiore. The voices of the Aos Si are Cameron Gergett and Dylan Smith. And the voice of Daichi is Zerreth.Dialogue editing by Angela Yih. Sound designed by Rebecca Liu. Mixed and mastered by Angela Yih. Script edited by Sara Roncero-Menendez. Original music by Hoa Pham. Season 3 cover art by Molly James. Series Logo by Macy Tang. For more information about the show, please go to our website residentsofproserpinapark.com Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

This week our good friend Blaze joins us as we discuss Daichi's attempt at atonement, Michinaga's over-correcting atonement, and the glorious and final defeat of Beroba. Then we shift to another amazing Kingohger episode as Daigorg obliterates an entire town, some more of the show's ongoing mysteries get brought up, and we work our way towards the debut of the castle's transformation. Finally, our feature topic is episode 46 of Kamen Rider Shinobi, a show we're more than happy to see again.  Casters Present:  Blue Gray Ultra Orange Spell  Show Notes: www.patreon.com/posts/87216105 Required Viewing: Kamen Rider Geats 46,  Ohsama Sentai Kingohger 22,  Kamen Rider Tycoon meets Shinobi  Watch on YouTube:    Feed the Castrangers and get $5 off your first order with SkipTheDishes! https://www.skipthedishes.com/r/6YaJc65HKg

A visit to the vet's office leads to some silly shenanigans, and a serious conversation with Jun and Sam.CREDITS: Residents of Proserpina Park is a production written and produced by Angela Yih. Directed by Angela Yih. The voice of Daichi is Zerreth. The voice of Mirai is Vida Shi. The voice of Alina is Angela Yih. The voice of Jun is Ben Pollizi. The voice of Dog is Sara Roncero-Menendez. The voice of Sam is G3. The voice of Ratoncito Perez is Sara Roncero-Menendez. And the voice of Drew is Ashley Dawson.Dialogue editing by Angela Yih. Sound designed by Rebecca Liu. Mixed and mastered by Angela Yih. Script edited by Sara Roncero-Menendez. Original music by Hoa Pham. Season 3 cover art by Molly James. Series Logo by Macy Tang. For more information about the show, please go to our website residentsofproserpinapark.comAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Spurs Chat: Discussing all Things Tottenham Hotspur: Hosted by Chris Cowlin: The Daily Tottenham/Spurs Podcast Hosted on Acast. See acast.com/privacy for more information.

Mirai finally gets her own solo episode only to be chased by Japanese creatures! Find out about the trouble she's gotten herself in and hopefully she survives it!CREDITS: Residents of Proserpina Park is a production written and produced by Angela Yih. Directed by Angela Yih. The voice of Mirai is Vida Shi. The voice of Daichi the Tanuki is Zerreth. The voice of Alina is Angela Yih. And the voice of Sam is G3.Dialogue editing by Angela Yih. Sound Design by Rebecca Liu. Mixed and mastered by Angela Yih. Script edited by Sara Roncero-Menendez. Original music by Hoa Pham. Season 3 cover art by Molly James. Series Logo by Macy Tang. For more information about the show, please go to our website residentsofproserpinapark.comAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Our buddy Cel is here this week for part of the episode, and Jerry joins us for the other part as we discuss news such as the Premium Moffuns, more figures, the release of Shin Kamen Rider, and plenty more. Then we discuss the disgusting return of Daichi, and Keiwa's tragic unlocking of his final form, The Adventures of Widdle Rita the Ten-Year-Old International Judge, and we wrap up the season of Fuuto PI with the incredible Reactor and the precocious Brachiosaurus Dopants.  Casters Present:  Blue Gray Orange Green North Knight  Show Notes: https://www.patreon.com/posts/85041640 Required Viewing: Kamen Rider Geats 40,  Ohsama Sentai Kingohger 16,  Fuuto PI 10-12  Watch on YouTube: https://www.youtube.com/watch?v=WMr6oKn0aAw   Feed the Castrangers and get $5 off your first order with SkipTheDishes! https://www.skipthedishes.com/r/6YaJc65HKg

The gang finally (or officially) meet Sam. And Drew gets a surprising heart to heart moment!CREDITS: Residents of Proserpina Park is a production written and produced by Angela Yih. Directed by Angela Yih. The voice of Mirai is Vida Shi. The voice of Alina is Angela Yih. The voice of Drew is Ashley Dawson. The voice of Jun is Ben Pollizi. The voice of Sam is G3. And the voice of Daichi is Zerreth.Dialogue editing by Angela Yih. Mixed and mastered by Rebecca Liu. Script edited by Sara Roncero-Menendez. Original music by Hoa Pham. Season 3 cover art by Molly James. Series Logo by Macy Tang. For more information about the show, please go to our website residentsofproserpinapark.comAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Prime mosse di mercato per il #milan con Daichi #kamada e Ruben Loftus-Cheek al centro dei movimenti di #calciomercato per la prossima stagione.Scarica MYSE, l'app di Fantamercato 2.0 e ricevi IN REGALO solo usando questo link un voucher da 5€ per cominciare a creare la squadra dei tuoi sogni: https://myse.page.link/radiorossonera E poi iscriviti alla Lega di Radio Rossonera e sfida i nostri speaker: https://myse.page.link/xkdQpm4YTbgN7Y7T8News Milan del giorno e tanto altro su RADIOROSSONERA.ITOrdine: “Impresa Inzaghi, ma per Pioli non è una briciola!”(VIDEO) Calhanoglu-Theo Hernandez, pace fatta? Le immagini parlano chiaroCondò: “Capisco il discorso di Maldini, ma allora perché confermare alcuni giocatori?”Calabria: “Brucia, ma le valutazioni alla fine. Poi toccherà alla società”Questo show fa parte del network Spreaker Prime. Se sei interessato a fare pubblicità in questo podcast, contattaci su https://www.spreaker.com/show/2355694/advertisement

If you want to try to answer the quiz questions Marli asks Hannah on this episode, go to our Instagram story @thehaikyuusummit and take the quiz before listening!! In this ep, Hannah's Haikyuu knowledge is tested, we find out if Daichi has survived, talk about a real life football comparison, and empathize with couple of quitters' battles.

The rise of Daichi Kamada. Daichi Kamada is a Japanese professional footballer who plays as an attacking midfielder or a forward for Bundesliga club Borussia Dortmund and the Japan national team. The Japan national football team, nicknamed the Samurai Blue, represents Japan in men's international football. It is controlled by the Japan Football Association, the governing body for football in Japan. Japan was not a major football force until the end of the 1980s, with a small and amateur team. Image Credit: kamadadaichi/instagram https://www.instagram.com/p/CmPgAc7PmKD/

This is a 2-part episode. In the first conversation, 1st-year student Daichi talks about role models with 1st-year student Mahoko. In the 2nd conversation, 1st-year student Kenta explains to Michael (teacher) about birthday celebrations around the world including Japan. Enjoy! --- Send in a voice message: https://anchor.fm/michael-blodgett5/message

We continue the series with 1st-year students. We have two great conversations packed into this one episode. First, Mahoko introduces Christmas in Japan with the help of Daichi. In the second conversation, Hagumi talks about Oshogatsu (New Year Holiday) with Misaki. As usual, there is a lot of talk about yummy Japanese food! Enjoy! Fried chicken on Christmas in Japan https://edition.cnn.com/travel/article/kfc-christmas-tradition-japan/index.html New Year`s things kadomatsu https://en.wikipedia.org/wiki/Kadomatsu kagami mochi https://en.wikipedia.org/wiki/Kagami_mochi hatsumode https://en.wikipedia.org/wiki/Hatsumōde osechi https://en.wikipedia.org/wiki/Osechi nanakusagayu https://www.tokyoweekender.com/2023/01/nanakusa-gayu-new-years-porridge-explained/ --- Send in a voice message: https://anchor.fm/michael-blodgett5/message

Welcome to the "Spurs Chat" podcast, hosted by YouTuber "Tottenham Fan Chris Cowlin". Talking about everything Tottenham Hotspur, from club news to transfer news, interviews and features. The daily Tottenham/Spurs Podcast.+ THANKS FOR LISTENING! Please FOLLOW, SHARE and leave a REVIEW.+ CONTENT:* SPURS CHAT: The Daily Tottenham/Spurs Podcast, hosted by Chris Cowlin* Watch Chris on YouTube: www.youtube.com/c/chriscowlin+ MEDIA ENQUIRIES ABOUT THE CHANNEL/PODCAST:* Enquiries: tottenhamfanchris@gmail.com* This is a Tottenham Hotspur fan channel, providing podcasts on breaking club news, fan interviews, legend interviews, following Spurs home and away, all around the world, including U23, U19, U18 and Spurs women matches. Chris Cowlin likes to present, with passion, the latest Spurs news and facts to Tottenham fans all around the world and to share his experiences of following this wonderful club. Also covering the England national team. Remember to follow this podcast, and COME ON YOU SPURS!* Chris is a regular on television and radio shows talking about all things Tottenham; most recently on BBC1, Sky Sports News, BBC Radio 5 Live and talkSport. Chris has also appeared on the recent documentaries on Tottenham Hotspur: "Sonsational: The Making of Heung-Min Son" (Korea's tvN, 2019), "All or Nothing: Tottenham Hotspur" (Amazon, 2020) and "Pochettino: le Film" (RMC Sport, 2021). Chris also presented two official videos for Tottenham Hotspur Football Club (2019) based on the opening of the Tottenham Hotspur Stadium. In May 2022 Chris fulfilled a lifelong dream - he played at the Tottenham Hotspur Stadium!+ CHANNEL SPONSORS:* Getir: https://getir.uk* Live Football On TV: https://www.live-footballontv.com/?utm_source=instagram&utm_medium=chris-cowlin* Nord VPN: https://nordvpn.com/tottenhamfans* talkSport: https://www.talksport.com: This Podcast has been created and uploaded by Spurs Chat. The views in this Podcast are not necessarily the views of talkSPORT.* Zouch Converters: https://www.zouchconverters.co.uk+ YOUTUBE CHANNEL AWARDS & NOMINATIONS:* Football Blogging Awards Winner 2019: "Best Club Content Creator"* Football Blogging Awards Finalist 2019: “Best Vlogger”* Football Content Awards Finalist 2020: “Best Club Content Creator"* Football Content Awards Finalist 2021: “Best Club Content Creator"* Football Content Awards Finalist 2021: “Best Content Creator"* Football Content Awards Finalist 2021: “Best In Video"* Football Content Awards Finalist 2022: “Best Podcast"+ LINKS:* Media Enquires: tottenhamfanchris@gmail.com* Website: https://www.spurschat.com* Twitter: https://www.twitter.com/chriscowlin* Instagram: https://www.instagram.com/chriscowlin* Facebook: https://www.facebook.com/TottenhamFanChrisCowlin* Tik Tok: https://www.tiktok.com/@chriscowlin* YouTube: https://www.youtube.com/user/cowlinchristopher* YouTube Member: Join this channel to get access to perks: https://www.youtube.com/channel/UCB9aWK0xfz2P-Ny2nsXGHrA/join* Purchase Books: https://www.amazon.co.uk/Chris-Cowlin/e/B002I7M0VA+ MUSIC:* Intro and outro music titled "The Trophies Are Coming" (by Gui Moraes) Hosted on Acast. See acast.com/privacy for more information.

Boo! A couple of weeks ago the Podcast Team had a small Halloween Party after researching Halloween in America and Japan. In this episode, Daichi and Mahoko talk about how Halloween became popular in Japan and some recent customs associated with Halloween. Enjoy! Intro music: Cantina Rag by Jackson F. Smith https://freemusicarchive.org --- Send in a voice message: https://anchor.fm/michael-blodgett5/message

Wow! We have now created 50 episodes. It has been great to see all the students contributing to our podcast. We hope to continue for at least 50 more. In today`s episode, we have two conversations about the recent summer holiday break. First, we have Mahoko and Hagumi, and then Koshiro and Daichi. Enjoy! Intro music: Cantina Rag by Jackson F. Smith https://freemusicarchive.org --- Send in a voice message: https://anchor.fm/michael-blodgett5/message

In this episode, 1st-year student Daichi takes us on a walking tour of Imai Town located down the road from our university. The episode includes Daichi's introduction to the historical ImaiTown followed by a tour of some sightseeing spots there with Teacher Michael and students Koshiro, Daichi, Mahoko, and Hagumi. Enjoy! Imai Town https://www.city.kashihara.nara.jp/kanko/en/imaicho.html Shounenji Temple https://www.imaicyou-syounenji.com/en.html Imanishi Ke https://www.japanese-wiki-corpus.org/building/Imanishi-ke%20Jutaku%20(Imanishi%20familys%20House).html Unomachi Cafe https://www.facebook.com/profile.php?id=100057594993993 Inondo Cafe https://www.instagram.com/inondcafe/?hl=ja Intro music: Cantina Rag by Jackson F. Smith https://freemusicarchive.org --- Send in a voice message: https://anchor.fm/michael-blodgett5/message

* Seth and Daichi are here * Douchie Howser * Seth's parties * Tom's Uber ride- Pennywise car * No time to be good  * Seth's good/bad stories  * Discount on rent for Daichi * Stinky Steakburger * Dad pee-farter * Fantasy football team names * A-boat-ppriation  ### For all audio versions of this garbage, please go HERE: Apple Podcasts: https://podcasts.apple.com/us/podcast/a-mediocre-time-with-tom-and-dan/id308614478 Stitcher: https://www.stitcher.com/podcast/a-mediocre-time-with-tom-and-dan-podcast/a-mediocre-time-with-tom-and-dan-show TuneIn: https://tunein.com/podcasts/Comedy/A-Mediocre-Time-with-Tom-and-Dan-Podcast-p393884/ iHeartRadio: https://www.iheart.com/podcast/1248-a-mediocre-time-with-tom-30696640/ Spotify: https://open.spotify.com/show/0IMs3hgNDuD6qI8ldHMWvH Thanks for watching us and we'll see you again tomorrow on Twitch at 10am-ish. Like - subscribe - and use the alert thingy. T&d

In this fun episode, 1st year students (Yuki and Daichi) introduce Japanese Manga and talk about their favorites. We also hear from 1st Year Students (Hagumi and Mihoko) and 2nd Year Student (Koshiro) on what their favorite manga are. Enjoy! Manga introduced in podcast: Captain Tsubasa https://en.wikipedia.org/wiki/Captain_Tsubasa KochiKami https://en.wikipedia.org/wiki/KochiKame:_Tokyo_Beat_Cops ONE PIECE https://en.wikipedia.org/wiki/One_Piece Haikyu!! https://en.wikipedia.org/wiki/Haikyu!! Hatarku Saibo https://en.wikipedia.org/wiki/Cells_at_Work! Intro music: Cantina Rag by Jackson F. Smith https://freemusicarchive.org --- Send in a voice message: https://anchor.fm/michael-blodgett5/message

What does it mean to be lead by the Holy Spirit? Is it just a feeling that you get? Do you find His leading through the Bible? Find out with Pr. Josiah and Daichi as they share this foundational skill for the Christian life!

In this episode, we have two conversations about Golden Week. First, we have 1st-year students Daichi and Yuki who talk about Showa Day (Greenery Day) and their recent fun on Golden Week. In our 2nd conversation, 1st-year students Hagumi and Mahoko focus on Children`s Day. Enjoy! Golden Week: https://en.wikipedia.org/wiki/Golden_Week_(Japan) Showa Day: https://en.wikipedia.org/wiki/Shōwa_Day Children`s Day: https://en.wikipedia.org/wiki/Children%27s_Day_(Japan) Koi-no-bori: https://en.wikipedia.org/wiki/Koinobori Kashiwa Mochi: https://en.wikipedia.org/wiki/Kashiwa_mochi Shobu Yu: https://www.japanese-wiki-corpus.org/culture/Shobuyu%20(bathwater%20with%20iris%20petals).html Intro music: Cantina Rag by Jackson F. Smith https://freemusicarchive.org --- Send in a voice message: https://anchor.fm/michael-blodgett5/message

We are back! The new school year has started here at Nara Medical University in Japan. We have some new 1st Year students that have joined the podcast team. In this episode, we meet Daichi and Mahoko. Enjoy! Sento (Japanese Public Bath) https://en.wikipedia.org/wiki/Sentō Washoku (Japanese cuisine) https://en.wikipedia.org/wiki/Japanese_cuisine Yokai Share House (TV Drama) https://wiki.d-addicts.com/Youkai_Share_House --- Send in a voice message: https://anchor.fm/michael-blodgett5/message

Lista dos animes analisados em nosso guia:00:01:03 Akebi-chan no Sailor-fuku00:12:23 Arifureta Shokugyou de Sekai Saikyou 2nd Season00:20:21 Fantasy Bishoujo Juniku Ojisan to00:25:24 Genjitsu Shugi Yuusha no Oukoku Saikenki Part 200:32:40 Hakozume: Kouban Joshi no Gyakushuu00:52:00 Kaijin Kaihatsu-bu no Kuroitsu-san00:59:40 Kimetsu no Yaiba: Yuukaku-hen01:17:53 Kotarou wa Hitorigurashi01:29:38 Leadale no Daichi nite01:36:54 Ousama Ranking01:46:35 Platinum End01:53:47 Princess Connect! Re:Dive Season 202:08:00 Sasaki to Miyano02:26:14 Shingeki no Kyojin: The Final Season Part 202:40:23 Shuumatsu no Harem03:01:57 Slow Loop03:14:25 Sono Bisque Doll wa Koi wo Suru03:31:25 Tropical-Rouge! Precure03:37:45 Vanitas no Karte Part 2Acompanhe nossas gravações na twitch de segunda a sexta a partir das 14h: www.Twitch.tv/ChaDeTrovaoMande seus comentários para nós em nosso e-mail: thunderreview@gmail.comAjude nosso podcast a continuar vivo em www.catarse.me/ChaDeTrovaoConheça nossas camisetas exclusivas: montink.com/chadetrovaoReferência Bibliográfica: http://bit.ly/CdTLinkTwitter: @Thunderbout @Rapha_Whatever @Igor_Nasuverse

Here are my thoughts and review on the 2022 Winter anime, In the Land of Leadale / Leadale no Daichi nite. find me: https://linktr.ee/tyrantdominus --- Send in a voice message: https://anchor.fm/tyrantdominus/message Support this podcast: https://anchor.fm/tyrantdominus/support

Call us at ‪(929) 356-6360‬ or shoot us an email at HotlinePod@gmail.com to ask for advice!

This week, we continue to navigate which shows will be in our mainstay lineup for the season and the ones we already can't stand. Jakia and Justin also make time to let the world know their dislike for Momonosuke, while Jenae tries to defend him. All this and more on Kaizoku Uncharted. Shows Sabikui Bisco The Genius Prince's Guide to Raising a Nation Out of Debt Love of Kill (Koroshi ai) World of Leadale (Leadale no Daichi nite) She Professed Herself Pupil of the Wise Man (Kenja no Deshi wo Nanoru Kenja) Orient Slow Loop Tokyo 24-ku (Tokyo 24th Ward) Requiem of the Rose King (Baraou no Souretsu) Police in a Pod (Hakozume: Kouban Joshi no Gyakushuu) Tribe Nine Futsal Boys!!!! Ryman's Club Cue! Life with an Ordinary Guy Who Reincared into a Total Fantasy Knockout The Case Study of Vanitas Season 2 My Dress-Up Darling The Strongest Sage with the Weakest Crest

It's week 3 in the weekly progression, its roundtable-style, we're sharing which shows we're committed to continue watching for the season. Jenae finally sees what Jakia is saying about Taiga in Tribe Nine and Justin and Jenae are still on their mountain about the quadruplets living in the van. Shows Sabikui Bisco The Genius Prince's Guide to Raising a Nation Out of Debt Love of Kill (Koroshi ai) World of Leadale (Leadale no Daichi nite) She Professed Herself Pupil of the Wise Man (Kenja no Deshi wo Nanoru Kenja) Orient Slow Loop Tokyo 24-ku (Tokyo 24th Ward) Requiem of the Rose King (Baraou no Souretsu) Police in a Pod (Hakozume: Kouban Joshi no Gyakushuu) Tribe Nine Ryman's Club Cue! My Dress-Up Darling The Strongest Sage with the Weakest Crest

This week on Kaizoku Uncharted, we sail into a new year and new season of anime! Tune in as we discuss and share our thoughts on which shows grabbed and lost our attention in this season's lineup! Shows Sabikui Bisco The Genius Prince's Guide to Raising a Nation Out of Debt Love of Kill (Koroshi ai) World of Leadale (Leadale no Daichi nite) She Professed Herself Pupil of the Wise Man (Kenja no Deshi wo Nanoru Kenja) Orient Slow Loop Tokyo 24-ku (Tokyo 24th Ward) Requiem of the Rose King (Baraou no Souretsu) Police in a Pod (Hakozume: Kouban Joshi no Gyakushuu) Tribe Nine Futsal Boys!!!! Ryman's Club Cue! Life with an Ordinary Guy Who Reincared into a Total Fantasy Knockout The Case Study of Vanitas Season 2 My Dress-Up Darling The Strongest Sage with the Weakest Crest

Welcome to the Get Along Podcast. Season 1 will be mainly focusing on young individuals to cover topics from social issues, personal stories and much more. Today's episode was such an amazing recording. I feel really great ful to have Daichi to be part of this passion project. I had the honor to speak with my good pal Daichi about his film Entering The Unknown and reviewing his first day of setting his mind that this is the path he wants to go forward to. For future updates and episodes of The Get Along podcast, feel free to follow us on Instagram FOLLOW US ON INSTAGRAM TO NOT MISS ANY UPDATES AND NEWS Jonathan Song (@getalongpodcast) • Instagram photos and videos GIVE US A REVIEW ON APPLE PODCAST Apple Podcast: ‎Get Along on Apple Podcasts BECOME A MONTHLY SUPPORTER Get Along • A podcast on Anchor - DAICHI WEBSITE http://daichisakane.com/ - Instagram @daichisakane - Filmbyte Production thefilmbyte.com -Email: sakanedean060@gmail.com --- Send in a voice message: https://podcasters.spotify.com/pod/show/late-thoughts/message Support this podcast: https://podcasters.spotify.com/pod/show/late-thoughts/support

Our special guest Airy talks about her OTP of Daichi and Kuroo, aka "Kurodai", from the smash hit anime and manga "Haikyuu" -- Airy's Carrd-- Fic rec links:https://archiveofourown.org/works/5380862https://archiveofourown.org/works/6603130https://archiveofourown.org/works/14939411https://archiveofourown.org/works/17056133Bonus KuroDai fic rec thread:https://twitter.com/ItsAiryBro/status/1282500361828392962Artists (on twitter):@Finnthebunneh @soapysandmich @beefkuto @suntails @jo_tuesday19 @mayuchi_hq @pon_kankan @amaSupport the show

Ever wondered what it's like working for one of the most influential companies in the world? Interested in life as a FAANG software engineer? Listen now to find out! --- Support this podcast: https://podcasters.spotify.com/pod/show/careerbites.ohmaneats/support